Mira Pharmaceuticals

Mira Pharmaceuticals | 1,002 followers on LinkedIn. Developing the next-generation FDA-approved novel synthetic THC analog | MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic pain without impurities or the adverse side effects of cannabis plant extracts.

Mira1a: A New Breakthrough in the World of Pharmaceutical Cannabinoids - Cannabis Tech

MIRA Pharmaceuticals, Inc. publie des données révolutionnaires issues de simulations d'intelligence artificielle -Le 04 décembre 2023 à 14:00

Thinking about buying stock in Macy's, Bitfarms, Nio Inc, Li Auto, or Mira Pharmaceuticals?

MIRAPRO 15 MG Tab, MIRTAZAPINE, SQUARE PHARMACEUTICALS LIMITED

MIRA Pharmaceuticals (NASDAQ:MIRA) Share Price, RNS News, Quotes, & Charts, MIRA

Nasdaq Exchange on X: Welcoming MIRA Pharmaceuticals to @NasdaqExchange to celebrate becoming #NasdaqListed! 🎉 $MIRA is an early-stage life sciences company focused on the development and commercialization of MIRA1a, a Novel synthetic

MIRA Pharmaceuticals & MIRALOGX Entered into an Exclusive Licensing Agreement for Ketamir-2

Mira Pharmaceuticals, cannabinoid drug developer, downsizes IPO to $7M (MIRA)

Mira Pharmaceuticals Inc

Biopharma Company Working On Synthetic THC Drug To Treat Anxiety Launches NASDAQ IPO - Mira Pharmaceuticals (NASDAQ:MIRA) - Benzinga

Mira Pharmaceuticals Inc

Following the Legalization of Recreational Cannabis, MIRA Pharmaceuticals Moves to Go Public

MIRA - candlestick chart analysis of MIRA Pharmaceuticals Inc.

formdrsa_016.jpg